Pharmocann Global Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 28,684 | 0.894% |
| Private Companies | 216,472 | 6.75% |
| Individual Insiders | 1,377,440 | 42.9% |
| General Public | 1,585,758 | 49.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 44%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 533,330 | ₪621.9k | 0% | no data | |||
| 369,918 | ₪431.3k | 0% | no data | |||
| 244,985 | ₪285.7k | 0% | no data | |||
| 216,472 | ₪252.4k | 0% | no data | |||
| 110,000 | ₪128.3k | 0% | no data | |||
| 69,207 | ₪80.7k | 0% | no data | |||
| 50,000 | ₪58.3k | 0% | no data | |||
| 21,746 | ₪25.4k | -16.8% | no data | |||
| 6,938 | ₪8.1k | 0% | no data |